Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Frieder A, Fersh M, Hainline R, et al. Pharmacotherapy of postpartum depression: current approaches and novel drug development. CNS Drugs. 2019;33(3):265–82.
2. Gunduz-Bruce H, Takahashi K, Huang MY. Development of neuroactive steroids for the treatment of postpartum depression. J Neuroendocrinol. 2022;34(2): e13019.
3. Patterson R, Balan I, Morrow AL, et al. Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions. Neuropsychopharmacology. 2024;49(1):67–72.
4. Bauman BL, Ko JY, Cox S, et al. Vital signs: postpartum depressive symptoms and provider discussions about perinatal depression—United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(19):575–81.
5. Bhatti NA, Jobilal A, Asif K, et al. Exploring novel therapeutic approaches for depressive disorders: the role of allopregnanolone agonists. Cureus. 2023;15(8): e44038.